Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
30 /100
MEDIUM RISK
Score updated Aug 28, 2026

ANAB — AnaptysBio, Inc. Dilution Risk Tracker

Track ANAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANAB — Get alerts when the score changes →

As of August 28, 2026, AnaptysBio, Inc. (ANAB) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. AnaptysBio, Inc. has a market capitalization of $1.62B, 29.10M shares outstanding, 206 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
35
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ANAB.
🔔 Track ANAB — Get forecast alerts →

Market Data

Market Cap$1.62B
Shares Outstanding29.10M
Float19.55M
Cash$248.47M
Debt$277.36M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 4.5% shares (2026Q1 vs prior)
206 institutional holders · 33.08M shares
#1 EcoR1 Capital, LLC 7.88M shares
#2 MORGAN STANLEY 3.58M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.71M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.40M
Days to Cover7.2
% of Float27.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2017-12-31
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-04-22
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ANAB Dilution Snapshot

AnaptysBio, Inc. (ANAB) has a DilutionScore of 30/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ANAB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANAB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ANAB
ANAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.